Our study found that M2-TAMs reversed the effect of cisplatin by secreting TGF-β1 to maintain the stemness of ESCC cells through the TGFβR1-Smad2/3 pathway. This evidence concerns the gene TGFBR1 and esophageal squamous cell carcinoma.